TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Severity of suicide behaviour
Endpoint domain: Adverse events/effects
Primary endpoint: Lethality of suicide attempt
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative rate of symptomatic radionecrosis at 2 years
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentrations of JYB1904
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentrations of IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse Events(AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle Thickness Variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in RV/LV ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1 repetition maximum bench press test (1RM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repetitive push up test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closed Kinetic Chain Upper Extremity Stability Test (CKCUES Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity Y-Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical expression of Oral Lichen Planus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA relapse free survival
Endpoint domain: Mortality/survival
Primary endpoint: Radiotherapy Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Gastrostomy compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Arachidonic acid and Adenosine diphosphate-induced platelet aggregation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximal Isometric Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal Dynamic Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Body Muscle Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of life in old age
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID-19 vaccination response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical efficacy of LAAB prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-item Revised Pain Neurophysiology Quiz
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 10-item Red Flags knowledge questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 13-item Health Care Providers' Pain and Impairment Relationship Scale (HC-PAIRS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Analogue Scale (VAS) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wong-Baker Face Pain Scale (FS) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech disfluencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carcinogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Study emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Average rating of chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of cytoplasmic TDP-43, TIA1 and/or p62 aggregates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood urea nitrogen (BUN) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatinine test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: High-Density Lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thrombo-inflammatory profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants with abnormal 12-lead ECG parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with abnormal vital signs measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of participants with at least one adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed Progression Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Time to Laboratory Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of occurrence of toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Total radioactivity excreted in urine and faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Forced Expiratory Volume in the First Second/Forced Vital Capacity Ratio (FEV1/FVC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygenation Stretch Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression-Free Survival (PFS) for patients with TDLN V15 ≤ 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS) for all patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adherence to the Mediterranean Diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in AD-associated deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of peripheral airway biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in usage of Coombs Test and other Labs Ordered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dose-limiting toxicity (DLT) of C-13-60 cells
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerable dose of C-13-60 cells
Endpoint domain: Adverse events/effects
Primary endpoint: Risky avoidance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decision-making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to death/discharge
Endpoint domain: Mortality/survival
Primary endpoint: Safety and tolerability of BSG005
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive Functioning Self-Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients with FIBSER score ≤ 2
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of lung cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of booster vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Elasticity of the hamstring muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants in HCV screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity of Esocheck/Esoguard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of Esocheck/Esoguard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak oxygen uptake (VO2peak) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation rate of eligible high-risk (ex-)smokers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants reporting hypovitaminosis symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Positive Intraoperative Indocyanine green test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of paraganglioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Foot Sole Sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time required for salivary pH recovery after Coca-Cola consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal value of salivary pH after Coca-Cola consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Subacute Low Back Pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term safety of BMN 270
Endpoint domain: Adverse events/effects
Primary endpoint: Pin prick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of participants with meningitis who died during hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: number of participants with meningitis who died during the first 24 months after hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: Evoked responses by action execution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Evoked responses by action observation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delta QSM of white matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in acne scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: postoperative visual analogue score (VAS SCORE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ-UI SF- Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in linear healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Subjects Achieving 4-Fold Increase in Neutralizing Antibody Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blood ketone difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Irritable Bowel Syndrome Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Internet Addiction Test (IAT) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in quality of caregiver-child interaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sPGA 0/1 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gun Holding Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Trigger Pulls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients able to undergo ABRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of IgG antibody for SARS-CoV-2 spike protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gastrointestinal Distress Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Annualised change in femoral neck bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Response rate (complete remission or CR with incomplete count recovery)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oligomenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in Vitamin D (25-hydroxyvitamin D) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Background-corrected Concentration-time Curve (AUC) From Start of Product Use, Extrapolated to Infinity (AUC Infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of the EPT
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Implant position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in sexual desire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: No urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Correction of knee flexion deformities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Perimetry of the affected limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetry of the affected limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Prognostic Liver Secretome signature (PLSec) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate as Assessed by RECIST 1.1 Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete and Partial Response Rate as Assessed by RECIST 1.1 Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: NIH stroke scale, NIHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Montreal cognitive assessment, MoCA-Beijing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mini-Mental State Examination, MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of ICU and/or ventilator requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Not Infected by COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Maximum concentration of THC in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from 0-360 minutes (AUC0-360)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful cannulation at first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recession Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root Coverage %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intestinal parasitic infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Tic Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tic Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of artery and veins of the neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change From Baseline in CAPS-5 Total Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in provider quality of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change of blood pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of intervention - delivery of AAC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Soft tissue health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-item itch scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observer scar assessment scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient scar assessment scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal high order aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient improvement regarding headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient improvement regarding visual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients improvement regarding fundus examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psoriasis Area and Life Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients fulfilling the inclusion criteria
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Discovery of circulating tumor cells (CTCs) and tumor cell products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Visual Analog Scale at 2 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Oswestry Disability Index at 2 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline spinal Range of Motion at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pushing force of both arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulling force of both arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time measurement tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of providers reporting tumor genetic testing strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serious Adverse Events rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Quality of Life in Epilepsy (QOLIE-31) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Neuro Quality of Life (Neuro-QOL) Item Bank v2.0 - Cognitive Function Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants who successfully completed the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who safely tolerated the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in proportions from post-intervention scores of HCP Practices scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Feasibility of the trial
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Considered as Complete TMA Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening or new-onset gastroesophageal reflux disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection rate of pathogenic microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Recurrence rate of subdural effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remote Care Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in Weekly-mean 24-hour Average Pain Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Quality of the ECG signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of the vascular Doppler signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of the blood pressure wave
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of samples sufficient for next-generation sequencing testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3+ I-hJAA-F11 related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic efficacy of I-hJAA-F11
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in credibility of the treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in expectations of the participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 14-day All-Cause Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Dental pain alleviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The rate of device success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Wisconsin Upper Respiratory Symptom Survey-21
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative pathological pCR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective response rate (ORR) on bone metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Technical feasibility of collecting continuous data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical feasibility of feeding continuous data to the predictive tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical feasibility of updating the predictive tool regularly
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Technical feasibility of reporting triggers to the RACE team
Endpoint domain: Resource use
Endpoint subdomain: Other resource use